Kancera's business concept is to develop drug candidates with the potential to cure or slow down the progression of cancer and offer those drug candidates to the pharmaceutical industry.
Kancera's business is the development of cancer drugs, starting with a new treatment concept and ending with a patent-pending drug candidate that is offered for sale once it has reached the clinical phase in the product development chain.